Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000689113 | SCV000816751 | benign | Gorlin syndrome | 2024-10-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001021767 | SCV001183424 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-10-19 | criteria provided, single submitter | clinical testing | The p.A1353V variant (also known as c.4058C>T), located in coding exon 23 of the PTCH1 gene, results from a C to T substitution at nucleotide position 4058. The alanine at codon 1353 is replaced by valine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003459676 | SCV004206617 | uncertain significance | Basal cell carcinoma, susceptibility to, 1 | 2023-06-23 | criteria provided, single submitter | clinical testing |